Reinventing Merck's Modern Lab: from pipettes to AI

Reinventing Merck's Modern Lab: from pipettes...

Suivant

Innovation Centers Powering Takeda's Digital Future

In this episode, host Tom Lehmann speaks with Sanjay Patel, Global Head of Innovation Capability Solutions & Services at Takeda, regarding how global collaboration and innovative leadership are reshaping the biotech landscape. Sanjay shares insights into the five-hub network he's ...  Afficher plus

Marketing Pharma's Future with GenAI and Purpose

Discover how digital innovation and Gen AI are reshaping pharma with Anvita Karara. Explore how patient-centricity, personalization, and responsible AI are driving better health outcomes and transforming engagement at scale. 

Épisodes Recommandés

Strategy& Insider Episode 27 - Bridging tradition and innovation with advanced computing
Strategy& Insider

In this episode, Clemens Utschig-Utschig, CTO at Boehringer Ingelheim, guides us through the digital and technological transformation of a 140-year-old family-owned pharmaceutical company. Explore how he utilizes data and technology to revolutionize drug development and personali ...  Afficher plus

Pharmaceutical Breakthroughs: The Cutting Edge of Biotechnology
Science and Technology

"Pharmaceutical Breakthroughs: The Cutting Edge of Biotechnology" - In this episode, we dive deep into the revolutionary world of biotechnology and its transformative impact on pharmaceuticals. Discover how cutting-edge innovations are reshaping drug development, accelerating vac ...  Afficher plus

#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
The Peter Attia Drive

View the Show Notes Page for This Episode

<a href= "https://petera ...

  Afficher plus

How AI Will Accelerate Breakthroughs in Biotechnology with Benchling CEO Sajith Wickramasekara
No Priors: Artificial Intelligence | Technology | Startups

Bringing new drugs to market is a costly, time-consuming endeavor. On top of that, most medicines fail at some point in the research and development phase. Sarah Guo is joined by Sajith Wickramasekara, co-founder and CEO of Benchling, a company that has not only become the centra ...  Afficher plus